{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:48:54Z","timestamp":1789084134043,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL116275"],"award-info":[{"award-number":["T32HL116275"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23HL15033"],"award-info":[{"award-number":["K23HL15033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.resmer.2025.101176","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:54:38Z","timestamp":1747122878000},"page":"101176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Anti-Mi-2 positive interstitial lung disease (ILD): A progressive disease comparable to other myositis-ILD"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6186-5732","authenticated-orcid":false,"given":"Bess M.","family":"Flashner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3215-4808","authenticated-orcid":false,"given":"Andrew J.","family":"Synn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia K.","family":"Munchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6190-624X","authenticated-orcid":false,"given":"Lida P.","family":"Hariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona K.","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney B.","family":"Montesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry S.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-391X","authenticated-orcid":false,"given":"Mary B.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6054-3558","authenticated-orcid":false,"given":"Rene S.","family":"Bermea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Hallowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmer.2025.101176_bib0001","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101176_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.resmer.2025.101176_bib0003","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/annrheumdis-2018-215004","article-title":"Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis","volume":"78","author":"Sabbagh","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resmer.2025.101176_bib0004","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1231-7","article-title":"Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody","volume":"20","author":"Sclafani","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.resmer.2025.101176_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.autrev.2018.10.004","article-title":"Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono- and multispecific immunoassays","volume":"18","author":"Damoiseaux","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.resmer.2025.101176_bib0006","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.resmer.2025.101176_bib0007","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2018.12.040","article-title":"Myositis-specific autoantibodies in dermatomyositis\/polymyositis with interstitial lung disease","volume":"397","author":"Li","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.resmer.2025.101176_bib0008","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01205-2020","article-title":"Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype","author":"Graham","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101176_bib0009","unstructured":"Myositis Specific 11 Antibody Panel | Test Detail | Quest Diagnostics nd. https:\/\/testdirectory.questdiagnostics.com\/test\/test-detail\/94777\/myositis-specific-11-antibodies-panel?cc=MASTER (accessed June 24, 2024)."},{"key":"10.1016\/j.resmer.2025.101176_bib0010","unstructured":"FMYO3 - Overview: myoMarker 3 Profile nd. https:\/\/www.mayocliniclabs.com\/test-catalog\/Overview\/75595 (accessed June 24, 2024)."},{"key":"10.1016\/j.resmer.2025.101176_bib0011","first-page":"277","article-title":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias","volume":"165","author":"Travis","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101176_bib0012","doi-asserted-by":"crossref","first-page":"E36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of Hypersensitivity Pneumonitis in Adults: an Official ATS\/JRS\/ALAT Clinical Practice Guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101176_bib0013","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: an Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101176_bib0014","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/cas.14715","article-title":"Treatment and relapse of interstitial lung disease in nivolumab-treated patients with non\u2013small cell lung cancer","volume":"112","author":"Sata","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.resmer.2025.101176_bib0015","article-title":"Acute Exacerbation in Interstitial Lung Disease","volume":"4","author":"Leuschner","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.resmer.2025.101176_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.chstcc.2023.100020","article-title":"ICU management of the patient with fibrotic interstitial lung disease","volume":"1","author":"Krishnan","year":"2023","journal-title":"CHEST Critical Care"},{"key":"10.1016\/j.resmer.2025.101176_bib0017","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis","volume":"194","author":"Collard","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101176_bib0018","first-page":"1291","article-title":"Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review Interstitial lung disease","volume":"10","author":"Gupta","year":"2023","journal-title":"BMJ Open Resp Res"},{"key":"10.1016\/j.resmer.2025.101176_bib0019","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1093\/rheumatology\/kead638","article-title":"Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease","volume":"63","author":"Hannah","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.resmer.2025.101176_bib0020","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12890-024-03326-w","article-title":"Prognostic value of myositis-specific antibodies in patients with idiopathic interstitial pneumonia","volume":"24","author":"Wakabayashi","year":"2024","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resmer.2025.101176_bib0021","doi-asserted-by":"crossref","unstructured":"Hannah J.R., Lawrence A., Martinovic J., Naqvi M., Chua F., Kouranos V., et al. Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease nd. https:\/\/doi.org\/10.1093\/rheumatology\/kead638.","DOI":"10.1093\/rheumatology\/kead638"},{"key":"10.1016\/j.resmer.2025.101176_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1319957","article-title":"Disease patterns and specific trajectories of anti-MDA5-related disease: a multicentre retrospective study of 70 adult patients","volume":"14","author":"de Boysson","year":"2024","journal-title":"Front Immunol"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:40:23Z","timestamp":1763829623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041225000236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":22,"alternative-id":["S2590041225000236"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101176","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Mi-2 positive interstitial lung disease (ILD): A progressive disease comparable to other myositis-ILD","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101176"}}